Skip to main content

Table 3 Correlation of IHC expression of mutation-specific antibodies and EGFR exon 19 deletion subtype analyzed by GeneScan, TaqMan and direct sequencing.

From: Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer

EGFR EXON 19 DELETION SUBTYPE 0 1+ 2+ 3+
15 bp
N = 17
0/17 (0%) 0/17 (0%) 2/17 (11%) 15/17 (89%)
9 bp
N = 4
2/4 (50%) 2/4(50%) 0/4 (0%) 0/4 (0%)
12 bp
N = 1
1/1 (100%) 0/1 (0%) 0/1 (0%) 0/1 (0%)
18 bp
N = 5
4/5 (80%) 1/5 (20%) 0/5 (0%) 0/5 (0%)
21 bp
N = 1
1/1 (100%) 0/1 (0%) 0/1 (0%) 0/1 (0%)
24 bp
N = 1
1/1 (100%) 0/1 (0%) 0/1 (0%) 0/1 (0%)